3 very impressive ASX quarterly updates from last week

ResMed Inc (ASX:RMD) and these ASX shares have just delivered very impressive quarterly updates. Here's what you need to know…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While earnings season hasn't officially started, a number of companies have just released their quarterly updates.

Here's a summary of three standout updates from last week:

ASX share price on watch represented by woman investor looking at ASX financial results on laptop

Image source: Getty Images

Bigtincan Holdings Ltd (ASX: BTH)

This artificial intelligence-powered sales enablement automation platform provider delivered a strong second quarter update last week. That update revealed that Bigtincan's strong form continued during the quarter, with annualised recurring revenue (ARR) increasing to $48.4 million. This represents growth of 50% on the prior corresponding period. It was driven predominantly by organic growth. Organic ARR came in at $40 million (up 42.9%) and ARR from acquisitions came in at $8.4 million.

Nitro Software Ltd (ASX: NTO)

Another impressive performer during the last quarter was this document productivity software company. Last week it released its fourth quarter update and revealed that its ARR reached US$27.7 million at the end of December. This was up 64% on the prior corresponding period and ahead of its previously upgraded guidance of US$26 million to US$27 million. Another positive was the increasing amount of revenue which is now from subscriptions. At the end of the period, subscription revenue had increased to approximately 58% of total revenue. It also comprised approximately 78% of revenue across the dominant Business sales channel.

ResMed Inc (ASX: RMD) 

A final result that caught the eye was the second quarter update from this medical device company. ResMed delivered a 9% increase in quarterly revenue to US$800 million and a 17% increase in net profit to US$206.4 million. This was ahead of the analyst consensus estimate for both revenue and earnings. Management advised that its growth was driven by a solid performance across the business. This includes its digital health business, which has been performing strongly thanks to the growing importance of out-of-hospital care.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends BIGTINCAN FPO. The Motley Fool Australia owns shares of and has recommended BIGTINCAN FPO. The Motley Fool Australia has recommended Nitro Software Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »